In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
201 News Items found
Three men standing in an airport
Feature
Exporting Expertise: How MSK Is Helping to Improve Cancer Care and Research in Ghana

Learn about a new initiative led by MSK pediatric hematologic oncologist Tanya Trippett that aims to improve cancer care and research in Ghana.
Cartoon of a hand offering cigarettes and another hand declining them.
Feature
6 Reasons to Quit Smoking if You Have Cancer

Learn from MSK experts about how to quit smoking if you have cancer. It starts with having honest conversations about smoking and nicotine addiction.
(Left to right) Sascha Roth, Luis Diaz, Imtiaz Hussain, Andrea Cercek, Avery Holmes, and Nisha Varughese.
Feature
Top Cancer Treatment Advances at MSK in 2022

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Here are some of the most important developments.
A researcher pipettes in the lab
MSK Research Highlights, June 25, 2024

New MSK research helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to FDA approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach that shows promise in detecting lung cancer; found checkpoint inhibitors were effective against endometrial and ovarian cancers with DNA-repair deficiency; and shed new light on mTOR's role in metabolic enzyme degradation.
Pictured: Cancer cell on blood vessel
In the Lab
Holding On and Hiding Out: How Cancer Cells Spread to the Brain and Thrive

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.
Genetic counselor Elise Fiala and pediatric cancer expert Michael Walsh
Finding
Study Demonstrates the Reasons to Screen Children with Cancer for Inherited Cancer Genes

The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.
Dr. Bob Li
Medical Oncologist Bob Li Featured in the Presidential Symposium at the 2020 World Conference on Lung Cancer

Dr. Bob Li will present registrational phase II data from the first-ever trial of a drug that blocks cancer gene KRAS.
Blood vessels supply tumors with the nutrients they need to grow.
Decoder
What Is Angiogenesis?

Cancer biologist Robert Benezra explains angiogenesis, the process by which new blood vessels form, and how it relates to cancer research.
Staff involved in implementing the new technology for diagnosing gene mutations in tumors include (from left) Marc Ladanyi, Angela Marchetti, Chris Lau, Laetitia Borsu, and Khedoudja Nafa.
New Technology Will Improve Molecular Testing of Tumors for Patients

Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients' cancers on an individual basis.
Meryl Jacobs poses with her husband and grandkids
FDA Approves Zenocutuzumab for Pancreatic and Lung Cancers With NRG1 Fusions 

The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small cell lung cancer with an alteration called an NRG1 gene fusion, based on a phase 2 clinical trial led by an MSK investigator.